Nonalcoholic steatohepatitis is associated with liver-related outcomes and all-cause mortality in chronic hepatitis B

Cited by (211)

Items 201–211 of 211

1. Investigating the Epidemiological Characteristics and Risk Factors of Hepatitis B and C Infections in the High-Risk Population of the Cities Covered by Jiroft University of Medical Sciences During the Years 2014-2023: A Descriptive Study
   Kiavash Hushmandi, Mehran Nikvarz, Habibe Vazirinasab, Mahdieh Ardaneh, Esmaeil Barkhori Mehni, Mohammad Hossein Khazaee‐Nasirabadi, Vahid Mashayekhi Mazar, Salman Daneshi · 2025 · مجله علمی دانشگاه علوم پزشکی رفسنجان
2. Differential NMR Lipoprotein Profiles and Prediction of Insulin Resistance and Metabolic Syndrome by LP-IR Among Adult Chronic Hepatitis B Patients
   Karen J. Campoverde Reyes, Javier Guevara, Hamidreza Karimi‐Sari, Daniela Goyes, Kamolyut Lapumnuaypol, Pir Ahmad Shah, Satinder Kaur, Margery A. Connelly, Zhenghui Gordon Jiang, Daryl Lau · 2025 · Journal of Clinical Medicine
3. Prevalence and Impact of Nonalcoholic Fatty Liver Disease in Patients with Chronic Hepatitis B
   琊芸 徐 · 2023 · Advances in Clinical Medicine
4. Association between diabetes and in‐hospital outcomes in patients with metabolic dysfunction‐associated steatotic liver disease hospitalized for cardiovascular disease: A nationwide database study
   Soichi Komaki, Michikazu Nakai, Yunosuke Matsuura, Kinuko Yamamoto, Hiroki Tanaka, Yuri Komaki, Masashi Yamaguchi, Kohei Moribayashi, Takeshi Ideguchi, Hiroshi Kawakami et al. · 2026 · Diabetic Medicine
5. Impact of Chronic Hepatitis B and Its Clinical Phases on Liver Fibrosis and Cirrhosis in Metabolic Dysfunction-Associated Steatotic Liver Disease
   Fajuan Rui, Jing Zhang, Hongshan Li, Yixuan Zhu, Yongfeng Yang, Liang Xu, Ming‐Hua Zheng, Qi Zheng, Haijun Huang, Youwen Tan et al. · 2026 · Clinical Gastroenterology and Hepatology
6. Altered renal disposition of adefovir in metabolic dysfunction–associated steatohepatitis using the fast-food diet and thioacetamide-induced model to extrapolate renal secretion
   Dominique O Farrera, Paxton A. Sample, Mina M Alaaldin, Paige Lindberg, Lucy Martinez-Guerrero, Jailyn M. Izu, Christopher S LaMadrid, Paige Lenzen-Hammerel, Lauren R. Radtke, Mason Ball et al. · 2026 · Drug Metabolism and Disposition
7. Coexistent Hepatitis B Virus and Metabolic Dysfunction-Associated Steatotic Liver Disease Under the New Definition: A New Era for Established Diseases
   Ahmed Tawheed, Abdulla A. Mahmoud, Hussein Hassan Aly, Mohamed El‐Kassas · 2026 · Livers
8. Routine laboratory model for identifying significant fibrosis in chronic hepatitis B
   Ting-Ting Wang, Yi-Li Chu, Yi-Qiang Lou, Rou-Yi Yang, Mao-Mao Pu, Lian-Jiang Shan, Lu Huang, Shan-Shan Chen, Hai-Jun Huang · 2026 · World Journal of Hepatology
9. Dynamic changes in controlled attenuation parameter (CAP) improve prognostic prediction for CHB patients with significant fibrosis and cirrhosis
   Xiaowei Ai, Mengyang Zhang, Shuyan Chen, Xinyu Zhao, Jialing Zhou, Tongtong Meng, Bingqiong Wang, Chenglin Sun, Han Xiao, Yankun Gao et al. · 2026 · Hepatology International
10. Berberine and metabolic dysfunction-associated steatotic liver disease: a global analysis of molecular mechanisms, translational challenges and research frontiers
    Fei Yu, Sihan Yin, ZHU Jiayu, Kewei Sun · 2026 · Frontiers in Nutrition
11. Why Outcomes Diverge in Chronic Hepatitis B with Steatotic Liver Disease: Lessons from Within-Study Contrasts
    Xiaoya Yang, Z.-G. Wang, Hongshan Wei · 2026 · Medicina